SAFETY AND EFFICACY OF ARA290, A NON-HEMATOPOIETIC ERYTHROPOIETIN DERIVED PEPTIDE, IN A 4 WEEKS PHASE II OPEN LABEL TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
Author(s):
Broek, M. van den; Allaart, C.F.; Brines, M.; Cerami, A.; Huizinga, T.W.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2013), Vol. 72, p. 620-620
